APA način citiranja

Seki, Y., Yamamoto, N., Tamura, Y., Goto, Y., Shibata, T., Tanioka, M., . . . Tamura, T. (2011). Phase I study for ridaforolimus, an oral mTOR inhibitor, in Japanese patients with advanced solid tumors. Springer-Verlag.

Čikaški stil citiranja

Seki, Yoshitaka, et al. Phase I Study for Ridaforolimus, an Oral MTOR Inhibitor, in Japanese Patients With Advanced Solid Tumors. Springer-Verlag, 2011.

MLA način citiranja

Seki, Yoshitaka, et al. Phase I Study for Ridaforolimus, an Oral MTOR Inhibitor, in Japanese Patients With Advanced Solid Tumors. Springer-Verlag, 2011.